Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1

Biochemical and Biophysical Research Communications

Volumn 414, Issue 1, 2011, Pages 233-239

  Zhang, Yi Kun ^a,c   Wang, Hua ^b   Leng, Yun ^d   Li, Ze Liang ^b   Yang, Yue Feng ^b   Xiao, Feng Jun ^b   Li, Qing Fang ^b   Chen, Xie Qun ^a   Wang, Li Sheng ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c The Second Artillery General Hospital PLA   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; IL 6; Mcl 1; MicroRNA; Multiple myeloma

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 29B; PROTEIN MCL 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BIOINFORMATICS; BONE MARROW; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERLEUKIN-6; MICRORNAS; MULTIPLE MYELOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

ADENOVIRIDAE;

EID: 80054066278     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.063     Document Type: Article

References (25)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
2. Chen C.Z., Li L., Lodish H.F., et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
3. Calin G.A., Liu C.G., Sevignani C., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA 2004, 101:11755-11760.
4. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci USA 2004, 101:2999-3004.
5. Croce C.M., Calin G.A. MiRNAs, cancer, and stem cell division. Cell 2005, 122:6-7.
6. Esquela-Kerscher A., Slack F.J. Oncomirs: microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
7. Calin G.A., Pekarsky Y., Croce C.M. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract. Res. Clin. Haematol. 2007, 20:425-437.
8. Pekarsky Y., et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006, 66:11590-11593.
9. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. Mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
10. Xu F., Sharma S., Gardner A., et al. Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 1998, 92:241-251.
11. Puthier D., Ŕegis IL-6 up-regulates Mcl-1 in human myeloma cells through JAK/STAT rather than Ras/MAP kinase pathway Nantes. France Eur. J. Immunol. 1999, 29:3945-3950.
12. Hardin J., Leod S., Grigorieva I., et al. Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 1994, 84:3063-3070.
13. Carrasco D.R., Tonon G., Huang Y., et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 2006, 9:313-325.
14. Shaughnessy J.D., Zhan F., Burington B.E., et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 2007, 109:2276-2284.
15. J.K. Ahluwalia, S.Z. Khan, K. Soni, et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication, Retrovirology 5 (2008) 117.
16. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
17. Milner A.E., Levens J.M., Gregory C.D. Flow cytometric methods of analyzing apoptotic cells. Methods Mol. Biol. 1998, 80:347-354.
18. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
19. Lim L.P., Lau N.C., Garrett-Engele P., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
20. Lomo J., Smeland E.B., Krajewski S., et al. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res. 1996, 56:40-43.
21. Altmeyer A., Simmons R.C., Krajewski S., et al. Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation. Immunity 1997, 7:667-677.
22. Kitada S., Andersen J., Akar S., et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Blood 1998, 91:3379-3389.
23. Kitada S., Zapata J.M., Andreeff M., et al. Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia. Blood 2000, 96:393-397.
24. Byrd J.C., Kitada S., Flinn I.W., et al. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood 2002, 99:1038-1043.
25. Herrant M., Luciano F., Loubat A., et al. The protective effect of phorbol esters on Fas-mediated apoptosis in T cells, transcriptional and postranscriptional regulation. Oncogene 2002, 21:4957-4968.